Results 121 to 130 of about 40,951 (233)

Minimally invasive treatments for benign prostatic hyperplasia: A narrative review. [PDF]

Medicine (Baltimore)
Zhang X, Liang T, Dong Y, Gao H.
europepmc   +1 more source

Methotrexate Toxicity in a Patient With Renal Failure Despite a Normal Methotrexate Concentration: A Case Report and Literature Review

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Methotrexate (MTX) is a folate antagonist widely used as a disease‐modifying antirheumatic drug (DMARD) in rheumatoid arthritis (RA), as well as in several malignancies and autoimmune disorders. Although low‐dose MTX (5–20 mg/week) is generally considered safe, it has a narrow therapeutic index, and toxicity can occur even at therapeutic doses,
Fatemeh Afra, Mahshad Ghoddusi, Mahsa Mottahedi, Maryam Albaji, Samira Kafan, Roya Saedpanah, Amir Shokri, Elham Nazar   +7 more
wiley   +1 more source

Rice bran oil ameliorates the symptoms of benign prostatic hyperplasia in male Wistar rats. [PDF]

Avicenna J Phytomed
Miah MA, Sathi MA, Hasib MG, Rahman M, Mahmud N, Shill MC, Reza HM, Hossain M, Rahman MM, Mostaid MS.   +9 more
europepmc   +1 more source

Cervical Skip Metastases and Extensive Central Venous Thrombosis as the Initial Presentation of High‐Grade Prostate Adenocarcinoma With Discordant PI‐RADS 3 Findings: A Case Report and Diagnostic Challenge

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Prostate cancer can initially present with cervical lymph node “skip” metastases and extensive central venous thrombosis, without pelvic or bone involvement. A PI‐RADS 3 lesion on mpMRI does not exclude high‐grade (Gleason 5 + 5 = 10) disease. Unexplained thrombosis in elderly men warrants prostate cancer investigation.
Yuchun Luo, Benhui Lai, Juncheng Huang
wiley   +1 more source

Relation of Prostatic and Urinary Bladder Ultrasound Parameters in Patients With Benign Prostatic Hyperplasia. [PDF]

Health Sci Rep
Pokharel BP, Thapa NB, Singh J, Dangi Y, Singh DB.   +4 more
europepmc   +1 more source

Treatment Regret in Patients Undergoing Minimally Invasive Treatments for Benign Prostatic Hyperplasia. [PDF]

J Clin Med
Lombardo R, Pastore AL, Turchi B, Franco A, Romagnoli M, Salhi YA, Fuschi A, Fiori C, Secco S, De Cillis S, Olivero A, Nacchia A, Cicione A, Cindolo L, Tema G, Tubaro A, De Nunzio C.   +16 more
europepmc   +1 more source

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery. [PDF]

BJUI Compass
Silva AB, Lebani BR, Pinto ER, Silva LT, Gouveia DS, de Lima H, Girotti ME, Skaff M, Almeida FG.   +8 more
europepmc   +1 more source

<i>Calamagrostis arundinacea</i> Extract Mitigates Testosterone Induced Prostatic Hyperplasia in Rats. [PDF]

Pharmaceuticals (Basel)
Kumbukgahadeniya P, Baek EB, Lee SH, Ha DI, Hong EJ, Song JY, Yoon WK, Kwun HJ.   +7 more
europepmc   +1 more source

The Role of N6‐Methyladenosine Modification in Health and Disease

MedComm, Volume 7, Issue 6, June 2026.
N6‐methyladenosine (m6A) is the most prevalent internal RNA modification in eukaryotes, acting as a pivotal epitranscriptomic regulator of RNA metabolism. This modification plays a dual role: it maintains physiological homeostasis under normal conditions but drives disease progression when dysregulated.
Linghuan Li, Yuanhai Sun, Wanfang Zheng, Lingqin Li, Yaqian Feng, Minyou Qi, Hanbing Li   +6 more
wiley   +1 more source

Correction: Prostatic artery embolization with glue for benign prostatic hyperplasia in elderly patients: three-year results. [PDF]

Radiol Med
Vizzuso A, Bazzocchi MV, Bacchiani M, Musacchia G, Spina A, Fragalà E, Venturi G, Petrella E, Gunelli R, Giampalma E, Renzulli M.   +10 more
europepmc   +1 more source